Daniel Wilson Now in Charge of iRhythm Technologies Finances

The new month has beget a new finance chief at iRhythm Technologies Inc. 

Daniel Wilson, the company’s executive vice president of Corporate Development and Investor Relations, has succeeded Brice Bobzien as chief financial officer (CFO). Bobzien stepped down from his position on Aug. 31 after two years; he will serve as an advisor to iRhythm Technologies until 2025 to ensure a “smooth transition” for Wilson. 

“Brice has been an outstanding leader at iRhythm over the past two years, making significant contributions to transform iRhythm’s finance organization during his tenure with the company,” iRhythm President/CEO Quentin Blackford said. “He has been invaluable in helping position our company to operate efficiently and effectively ahead of immense growth, leading with a disciplined and rigorous approach to financial management, operational excellence, and strategic development. We wish him all the best as he shifts his attention towards personal and family matters.”
 
Wilson has been iRhythm’s executive vice president of Corporate Development and Investor Relations since April 2023 and previously served as executive vice president of Corporate Development, Corporate Strategy, and Investor Relations since June 2019. Previously, he was director and head of Business Development at Penumbra Inc., a global healthcare company focused on innovative therapies. Before Penumbra, he held various positions at J.P. Morgan between August 2006 and May 2016, most recently as executive director in the Healthcare Investment Banking group, focused on digital health, medical technology, and emerging healthcare companies. Earlier in his career, he held various positions in Piper Jaffray’s Healthcare Investment Banking group. He started his career at KPMG as an audit associate.

Wilson earned a bachelor of science degree in business ddministration from California Polytechnic State University at San Luis Obispo.

“We are thrilled to have Dan take over the finance organization and are confident in the expanded leadership he will provide as our next CFO. Dan has a long history with iRhythm, advising the company on its initial public offering and then joining iRhythm in 2019. In his time with the company, Dan has been a trusted partner, strategic leader, unwavering brand ambassador, and a passionate champion of iRhythm’s mission,” Blackford stated. “His strong strategic background, industry experience, and financial acumen make him uniquely qualified to help lead the organization into our next phase of growth.”
 
iRhythm is a digital healthcare company that creates solutions for detecting, predicting, and preventing disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. The firm is based in San Francisco.